ES8106891A1 - Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas - Google Patents

Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas

Info

Publication number
ES8106891A1
ES8106891A1 ES496038A ES496038A ES8106891A1 ES 8106891 A1 ES8106891 A1 ES 8106891A1 ES 496038 A ES496038 A ES 496038A ES 496038 A ES496038 A ES 496038A ES 8106891 A1 ES8106891 A1 ES 8106891A1
Authority
ES
Spain
Prior art keywords
medicaments
hydroxyalkyl
piperidines
trihydroxy
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES496038A
Other languages
English (en)
Other versions
ES496038A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES496038A0 publication Critical patent/ES496038A0/es
Publication of ES8106891A1 publication Critical patent/ES8106891A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 2-HIDROXIALQUIL-3,4,5-TRIHIDROXIPIPERIDINA DE FORMULAS (I) Y (II). PARA OBTENER LOS DERIVADOS DE FORMULA (I) SE HACE REACCIONAR UN COMPUESTO DE FORMULA (III) CON DIOXIDO SULFURICO. MEDIANTE POSTERIOR REACCION CON BASES, REDUCCION Y ALQUILIZACION SE OBTIENEN LOS COMPUESTOS CON DIFERENTES RADICALES. PARA OBTENER LOS DERIVADOS DE FORMULA (II) SE HACE REACCIONAR UN ALDEHIDO DE FORMULA (IV), DONDE BZ ES BENCILO Y PH FENILO, CON UN COMPUESTO DE FORMULA R2MGX, DONDE X ES UN HALOGENO. EL PRODUCTO OBTENIDO SE HACE REACCIONAR CON SODIO EN AMONIACO. DE APLICACION EN EL TRATAMIENTO DE DIABETES, HIPERLIPOPROTEINEMIA, GASTRITIS Y ADIPOSITIS. *FORMULA*
ES496038A 1979-10-19 1980-10-17 Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas Expired ES8106891A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792942365 DE2942365A1 (de) 1979-10-19 1979-10-19 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES496038A0 ES496038A0 (es) 1981-09-16
ES8106891A1 true ES8106891A1 (es) 1981-09-16

Family

ID=6083911

Family Applications (1)

Application Number Title Priority Date Filing Date
ES496038A Expired ES8106891A1 (es) 1979-10-19 1980-10-17 Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas

Country Status (15)

Country Link
US (1) US4348402A (es)
EP (1) EP0027908B1 (es)
JP (2) JPS5665869A (es)
AT (1) ATE4642T1 (es)
AU (1) AU6319480A (es)
CA (1) CA1161439A (es)
DE (2) DE2942365A1 (es)
DK (1) DK441180A (es)
ES (1) ES8106891A1 (es)
FI (1) FI803264L (es)
GR (1) GR71207B (es)
HU (1) HU181203B (es)
IL (1) IL61285A (es)
NO (1) NO802939L (es)
ZA (1) ZA806399B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582758B2 (en) * 1984-06-28 1989-04-13 Mect Corporation Sialic acid derivatives, galactose derivatives and method for producing the same
US4634765A (en) * 1984-12-18 1987-01-06 Merrell Dow Pharmaceuticals Inc. Homodisaccharide hypoglycemic agents
US5231185A (en) * 1985-11-19 1993-07-27 Cornell Research Foundation, Inc. Monosaccharide analog-based glycosidase inhibitors
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US5221746A (en) * 1988-11-03 1993-06-22 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5310745A (en) * 1988-11-03 1994-05-10 G. D. Searle & Co. Antiviral compounds
US5026713A (en) * 1989-08-29 1991-06-25 Monsanto Company 1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activity
US5175168A (en) * 1989-07-27 1992-12-29 Monsanto Company Intermediates for 1,2-dideoxy-2-fluoronojirimycin
US5025021A (en) * 1989-07-27 1991-06-18 Monsanto Company 1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors
US5218121A (en) * 1989-08-29 1993-06-08 Monsanto Company Synthesis of 1,3-dideoxy-3-fluoronojirimycin
US5130320A (en) * 1989-08-29 1992-07-14 Monsanto Company Glycosidase inhibiting 1,3-dideoxy-3-fluoronojirimycin
JPH0556770U (ja) * 1991-10-25 1993-07-27 井関農機株式会社 走行クロ−ラにおけるスライド装置
AU9646598A (en) * 1997-10-23 1999-05-10 Takeda Chemical Industries Ltd. Fused imidazopyridine derivatives, process for producing the same, and preparations containing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
GB1554117A (en) * 1976-12-23 1979-10-17 Bayer Ag Inhibitors for a-glucosidases
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS5470955A (en) * 1977-11-15 1979-06-07 Baasatairu Mfg Ltd Rotary type combine
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS5515365A (en) * 1978-07-20 1980-02-02 Mitsubishi Heavy Ind Ltd Hull remodelling method

Also Published As

Publication number Publication date
ES496038A0 (es) 1981-09-16
CA1161439A (en) 1984-01-31
FI803264L (fi) 1981-04-20
EP0027908A2 (de) 1981-05-06
GR71207B (es) 1983-04-11
HU181203B (en) 1983-06-28
NO802939L (no) 1981-04-21
IL61285A0 (en) 1980-12-31
DE2942365A1 (de) 1981-05-14
EP0027908B1 (de) 1983-09-14
JPS5665869A (en) 1981-06-03
JPS646191B2 (es) 1989-02-02
IL61285A (en) 1984-10-31
DE3064835D1 (en) 1983-10-20
AU6319480A (en) 1981-04-30
DK441180A (da) 1981-04-20
US4348402A (en) 1982-09-07
JPH01131156A (ja) 1989-05-24
EP0027908A3 (en) 1981-08-05
ZA806399B (en) 1981-10-28
ATE4642T1 (de) 1983-09-15

Similar Documents

Publication Publication Date Title
ES8402591A1 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
NZ208529A (en) 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions
ES8106891A1 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
IL49204A (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
ES8800272A1 (es) Un procedimiento para la preparacion de polipeptidos.
ES8406477A1 (es) Procedimiento para la preparacion de b-carbolinas
ES8203897A1 (es) Procedimiento para la obtencion de imidazoazoalquenamidas
IL62198A (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
IL58193A (en) 3,4,5-trihydroxypiperidine derivatives,their production and pharmaceutical compositions containing them
ES8103043A1 (es) Procedimiento para la obtencion de derivados de 2-hidroxime-til-3,4,5-trihidroxipiperidinas
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
ES8305783A1 (es) Procedimiento para la obtencion de derivados de aminociclitol saturados.
ES8203334A1 (es) Procedimiento para la obtencion de dehidropeptidos
ES8200871A1 (es) Procedimiento para la obtencion de derivados de 2-amino-3,4-dihidropiridina
ES8306481A1 (es) Procedimiento para la obtencion de sulfamidas anulares.
ES471125A1 (es) Procedimiento para preparar derivados de 1-aminoindolina
ES8203843A1 (es) Procedimiento para la obtencion de amidas de acido 1,4-dihi-dropiridin-4-carboxilico
DE3660959D1 (de) Benz-trisubstituted 2-aminotetralins
ES8203087A1 (es) Procedimiento para la obtencion de imidazolil-indeno-tiofe- nos
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
ES483277A1 (es) Procedimiento para la obtencion de n-amino-3,4,5-tihidroxi- piperidinas
ES8201141A1 (es) Procedimiento para preparar derivados de s-fenilseleno-bencimidazol.